Skip to search formSkip to main contentSkip to account menu

IL32 gene

Known as: TAIFd, IL32, NATURAL KILLER CELL TRANSCRIPT 4 
This gene is involved in cytokine-mediated immunity.
National Institutes of Health

Related topics

Related topics

8 relations
Cell Proliferation Regulatory ProcessCytokine Receptor BindingCytokine SignalingIL32 protein, human

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Angioinhibitory Action of NK4 Involves Impaired Extracellular Assembly of Fibronectin Mediated by Perlecan-NK4 Association*
NK4, a fragment of hepatocyte growth factor (HGF), exerts bifunctional action as a competitive antagonist against HGF and its… 
Review
2008
Review
2008
NK4 gene therapy targeting HGF-Met and angiogenesis.
Based on the background that hepatocyte growth factor (HGF) and Met/HGF receptor tyrosine kinase play a definite role in tumor… 
Highly Cited
2007
Highly Cited
2007
NK4, an antagonist of hepatocyte growth factor (HGF), inhibits growth of multiple myeloma cells: molecular targeting of angiogenic growth factor.
Hepatocyte growth factor (HGF) promotes cell growth and motility and also increases neovascularization. Multiple myeloma (MM… 
2006
2006
Mast Cell and Neutrophil Peptidases Attack an Inactivation Segment in Hepatocyte Growth Factor to Generate NK4-like Antagonists*
Hepatocyte growth factor (HGF) is a plasminogen-like protein with an α chain linked to a trypsin-like β chain without peptidase… 
2005
2005
Enhanced suppression of tumor growth using a combination of NK4 plasmid DNA-PEG engrafted cationized dextran complex and ultrasound irradiation
This investigation aims to determine experimentally whether or not ultrasound (US) irradiation is effective in enhancing the in… 
2004
2004
Gene Therapy with Secretory Leukoprotease Inhibitor Promoter-Controlled Replication-Competent Adenovirus for Non-Small Cell Lung Cancer
Secretory leukoprotease inhibitor (SLPI) is highly expressed in almost all non-small cell lung cancers (NSCLCs), but not in the… 
2004
2004
Gene transduction of NK4, HGF antagonist, inhibits in vitro invasion and in vivo growth of human pancreatic cancer
In this study, we investigated the therapeutic effects of adenovirally-mediated transfer of the sequence of NK4, an antagonist… 
2003
2003
Cell-based protein delivery system for the inhibition of the growth of pancreatic cancer: NK4 gene-transduced oral mucosal epithelial cell sheet.
PURPOSE Pancreatic resection for pancreatic cancer is the only curative modality, but the high incidence of local recurrence… 
2002
2002
Tumor suppression induced by intratumor administration of adenovirus vector expressing NK4, a 4-kringle antagonist of hepatocyte growth factor, and naive dendritic cells.
NK4, a 4-kringle antagonist of hepatocyte growth factor (HGF), is a potent inhibitor of tumor angiogenesis and functions… 
2002
2002
The human tachykinin NK1 (short form) and tachykinin NK4 receptor: a reappraisal.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)